Xsite Health

xsitehealth.com

We bring dental, health & vision services to the workplace,so that employees can attain a higher degree of work-life balance and the workplace can regain lost productivity. All of this helps provide a healthier, happier environment with a “win” for everyone.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ZEBLOK COMPUTATIONAL ANNOUNCES PARTNERSHIP WITH LAUFER CENTER AND CEWIT - COVID-19 DRUG DISCOVERY

Zeblok Computational, The Laufer Center, CEWIT | July 20, 2020

news image

Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok’s secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster. The Laufer Center simulations focus on 3 key proteins of the SARS-CoV-2 virus to pinpoint more precisely which drug candidates have the best binding affinity to various protein tar...

Read More

Business Insights, PHARMA TECH

CONTINUUS PHARMACEUTICALS ADOPTS DIGITAL VALIDATION

CONTINUUS Pharmaceuticals | March 15, 2023

news image

On March 14, 2023, ValGenesis, Inc., a leading enterprise validation lifecycle management solutions provider, announced that CONTINUUS Pharmaceuticals has successfully implemented the ValGenesis Validation Lifecycle Management System (VLMS) for efficient management of validation processes across the company in a 100% digital format. CONTINUUS Pharmaceuticals is a rapidly growing small business specializing in end-to-end integrated continuous manufacturing (ICM) of pharmaceutical...

Read More

OBI PHARMA ANNOUNCES OBI-999 PRESENTATION AT 2020 WORLD ADC DIGITAL MEETING

OBI Pharma | September 14, 2020

news image

OBI Pharma, Inc, a leader in Glycosphingolipid Immuno-Oncology therapeutics targeting the Globo Series antigens (Globo H and SSEA-4) and chemotherapeutics targeting AKR1C3, today announced a scientific presentation will be held for OBI-999 (anti-Globo H targeted ADC) at the World ADC Digital Scientific meeting on Sept 16, 2020. The scientific presentation titled, "A Novel Globo H-targeting Antibody-drug Conjugate: OBI 999" with a follow-up live discussion and question session will be l...

Read More

Pharma Tech

MODERNA HITCHES A RIDE WITH UBER TO BOOST VACCINE CONFIDENCE—AND, OF COURSE, DRIVE ACCESS

Moderna | January 15, 2021

news image

COVID-19 vaccine maker Moderna is looking for a lift from Uber—a collaboration lift, that is. The two companies say they're planning to work together to promote vaccine confidence and ease access to coronavirus shots. Early ideas include promoting vaccine safety on the Uber network and through in-app messages as well as incorporating Uber rides into the vaccination scheduling process. While those details are still in the works, the appeal of Uber as a part...

Read More
news image

ZEBLOK COMPUTATIONAL ANNOUNCES PARTNERSHIP WITH LAUFER CENTER AND CEWIT - COVID-19 DRUG DISCOVERY

Zeblok Computational, The Laufer Center, CEWIT | July 20, 2020

Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok’s secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster. The Laufer Center simulations focus on 3 key proteins of the SARS-CoV-2 virus to pinpoint more precisely which drug candidates have the best binding affinity to various protein tar...

Read More
news image

Business Insights, PHARMA TECH

CONTINUUS PHARMACEUTICALS ADOPTS DIGITAL VALIDATION

CONTINUUS Pharmaceuticals | March 15, 2023

On March 14, 2023, ValGenesis, Inc., a leading enterprise validation lifecycle management solutions provider, announced that CONTINUUS Pharmaceuticals has successfully implemented the ValGenesis Validation Lifecycle Management System (VLMS) for efficient management of validation processes across the company in a 100% digital format. CONTINUUS Pharmaceuticals is a rapidly growing small business specializing in end-to-end integrated continuous manufacturing (ICM) of pharmaceutical...

Read More
news image

OBI PHARMA ANNOUNCES OBI-999 PRESENTATION AT 2020 WORLD ADC DIGITAL MEETING

OBI Pharma | September 14, 2020

OBI Pharma, Inc, a leader in Glycosphingolipid Immuno-Oncology therapeutics targeting the Globo Series antigens (Globo H and SSEA-4) and chemotherapeutics targeting AKR1C3, today announced a scientific presentation will be held for OBI-999 (anti-Globo H targeted ADC) at the World ADC Digital Scientific meeting on Sept 16, 2020. The scientific presentation titled, "A Novel Globo H-targeting Antibody-drug Conjugate: OBI 999" with a follow-up live discussion and question session will be l...

Read More
news image

Pharma Tech

MODERNA HITCHES A RIDE WITH UBER TO BOOST VACCINE CONFIDENCE—AND, OF COURSE, DRIVE ACCESS

Moderna | January 15, 2021

COVID-19 vaccine maker Moderna is looking for a lift from Uber—a collaboration lift, that is. The two companies say they're planning to work together to promote vaccine confidence and ease access to coronavirus shots. Early ideas include promoting vaccine safety on the Uber network and through in-app messages as well as incorporating Uber rides into the vaccination scheduling process. While those details are still in the works, the appeal of Uber as a part...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us